Healthcare systems around the world are under unprecedented financial pressure.
Humira has set a record for the highest gross-selling drug in the world and contributed 63 percent to AbbVie’s revenue in 2016 alone and expectations are high the blockbuster drug will continue to perform.
The ability to edit the human genome has been eagerly anticipated for many years.
While uncertainty has been a theme for most sectors in the UK over recent months, the medical technology (medtech) industry has suffered more than most.
Heart surgery, prenatal care, organ transplants, and blood transfusions.
There is bad news for global pharmaceutical and medical devices companies; China has developed a set-in-stone timetable to conduct government-driven price management and reimbursement controls.
Artificial intelligence (AI) has already started to revolutionise healthcare, but this is only the beginning of a new era — we will see an unimaginable potential coming to fruition over the next several years.
In recent years licensing deals have dominated the pharmaceutical industry.
While the tale of Hansel and Gretel – two children that manage to defeat a wicked witch that’s intent on getting them fat – is a nice enough story, in the real world this is a monster that is not so easily beaten.
Following the ransomware cyber attacks on the NHS last week, the public has been reminded of the challenges to security that come with increased use of wireless devices and electronic medical records.
A new American Cancer Society study revealed that as sugary drinks have become more affordable around the world, global sugar consumption has climbed.
People are today surrounded by an overwhelming amount of information and knowledge on almost any topic of interest, including a variety of online symptom-checkers that encourage self-diagnosis.
Biosimilar trials — testing an almost identical copy of a drug originally manufactured by a different company — have exploded in recent years.
Since the UK triggered Article 50 — the formal European Union exit clause — in March the pharma industry has been closely watching where the European Medicines Agency (EMA) is going to relocate.
Between October 2015 and October 2016, the NHS in Scotland reported 1,150 cases of C.
Google’s life-science arm, Verily, is initiating Project Baseline — a 10,000 person study to gain a better understanding of people’s predisposition to various illnesses.
In developed markets, especially the US, pharmaceutical companies are facing a period of uncertainty, with pricing and reimbursements concerns causing significant barriers to revenue potential.
Genetic testing for diseases is becoming increasingly common worldwide, in part due to the dramatic fall in costs.
We all know that getting a good night’s rest is important, but recent studies have shown skimping on sleep could shorten your lifespan.
Well-established drug development powerhouses Roche, Celgene, and Novartis are the biggest pharma firms by oncology revenue right now and are set to hold onto the top spots over the next five years.
There has been a marked shift in the pharmaceutical companies that began the most clinical trials last year.
Treatment for HIV varies depending where you live, but the US is doing far less than could be expected.
As the House of Representatives votes on Trump’s new healthcare bill, let’s see how the budget will affect health in the US.
As the rest of the world is increasing its investment in biomedical research, the US has been cutting research funding rather steadily over the past ten years.
US president Donald Trump’s newly introduced Obamacare replacement, the American Healthcare Act, would fulfil the president’s promise to defund Planned Parenthood.
Times are tough in the healthcare industry and the rise of pharmacoeconomics — when the value of one pharmaceutical drug or drug therapy is compared to another — is not making life any easier for big pharma.
Wearable technology is being increasingly used outside of the limited hospital environment.
Across the world, people are living longer and healthier lives, a study by the Imperial College of London shows.
At the recent Munich Security Conference, Microsoft founder turned philanthropist Bill Gates warned millions might be at risk from bio-terrorism, through the activities of amateur scientists — AKA bio-hackers.